Actively Recruiting
The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life
Led by Wenjing Zhou · Updated on 2024-08-02
600
Participants Needed
1
Research Sites
149 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective observational study aims to assess the health-related quality of life (HRQoL) of 200 children (ages 5-16) with bronchial asthma, allergic rhinitis, or both, and their 200 parents, comparing 100 children receiving specific immunotherapy with 100 receiving routine treatment. Using EQ-5D-Y(EuroQol five dimensions questionnaire, youth version), disease-specific scales, and newly developed Chinese versions of EQ-5D-Y and EQ-HWB-S (EuroQol health and well-being questionnaire, short version), the study evaluates HRQoL changes over 1 and 2 years and explores the impact on caregiver burden and spillover effects. A control group of 100 healthy children and their parents will be included. Data collection involves baseline and follow-up surveys, clinical data from medical records, and statistical analyses to compare treatment effects and validate measurement tools.
CONDITIONS
Official Title
The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 5 to 16 years
- Diagnosed with bronchial asthma, allergic rhinitis, or both, with symptoms lasting 4 weeks or more
- Guardian has signed informed consent
- Able to understand and complete questionnaires
- Receiving outpatient or inpatient care at Renji Hospital Pediatrics Department in Shanghai
- Parents are primary caregivers, present at hospital visit, signed informed consent
- Parents able to understand and complete questionnaires
You will not qualify if you...
- Children with poor compliance
- Children who have already received specific immunotherapy at another hospital
- Children unable to read and complete questionnaires independently
- Children lost to follow-up or discontinued treatment
- Parents unwilling to sign informed consent
- Parents unable to complete questionnaires due to physical or educational limitations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China, 200127
Actively Recruiting
Research Team
W
Wenjing Zhou
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here